Evidence map›Paper›PMID 29310747›Full record

ArticleEpidemiology and infection2018

Population-based seroprevalence of Puumala hantavirus in Finland: smoking as a risk factor.

F Latronico, S Mäki, H Rissanen, J Ollgren, O Lyytikäinen, O Vapalahti, J Sane

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

F LatronicoDepartment of Health Security,National Institute for Health and Welfare,FI-00271 Helsinki,Finland.ORCID 0000-0001-8949-6505
S MäkiDepartment of Virology,University of Helsinki and Helsinki University Hospital,Helsinki,Finland.
H RissanenDepartment of Public Health Solutions,National Institute for Health and Welfare,FI-00271 Helsinki,Finland.
J OllgrenDepartment of Health Security,National Institute for Health and Welfare,FI-00271 Helsinki,Finland.
O LyytikäinenDepartment of Health Security,National Institute for Health and Welfare,FI-00271 Helsinki,Finland.
O VapalahtiDepartment of Virology,University of Helsinki and Helsinki University Hospital,Helsinki,Finland.
J SaneDepartment of Health Security,National Institute for Health and Welfare,FI-00271 Helsinki,Finland.
Finnish Institute for Health and Welfare · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Puumala hantavirus (PUUV) causes hemorrhagic fever with renal syndrome in humans, that is an endemic disease in Finland. We estimated the seroprevalence of PUUV in Finland and explored risk factors and disease associations by using unique survey data with health register linkage. A total of 2000 sera from a nationwide health survey from 2011, representative of the adult population, were screened for PUUV IgG by immunofluorescence assay. We performed statistical analysis adjusting for stratified cluster design and taking into account sampling weights. In total, 254 sera among 2000 tested were PUUV-IgG-positive resulting in a weighted seroprevalence of 12.5%, (95% CI 10.9-14.4), mirroring known age and regional variation in reported incidence. No associations between PUUV-seropositivity and chronic diseases including cardiovascular (including hypertension), pulmonary, kidney disease and cancer were observed. Smoking was significantly associated with seropositivity (adjusted OR 1.54; 95% CI 1.16-2.04). In addition, significant dose-response relations were found for the number of cigarettes smoked daily (OR 1.14; 95% CI 1.12-1.28). The results are important for disease burden assessment and guide intervention strategies, highlighting also the role of smoking prevention.

Indexed as

AdultAgedAged, 80 and overFemaleFinlandHemorrhagic Fever with Renal SyndromeHumansMaleMiddle AgedPrevalencePuumala virusRisk FactorsSeroepidemiologic StudiesSmokingFinlandhantavirusrisk factorseroprevalencezoonosis

Identifiers

PMID29310747
PMCPMC9134512
OpenAlexW2790580930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.